Evidence map›Paper›PMID 35767950›Full record

ArticleCell reports2022

B cells expressing IgM B cell receptors of HIV-1 neutralizing antibodies discriminate antigen affinities by sensing binding association rates.

Md Alamgir Hossain, Kara Anasti, Brian Watts, Kenneth Cronin, Ronald Derking, Bettina Groschel, Advaiti Pai Kane, R J Edwards, David Easterhoff, Jinsong Zhang and 8 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Deciphering the immunomodulatory mechanisms ofFrontiers in cell and developmental biology · 2025
    Article
  7. Dynamics and Activation of Membrane-Bound B Cell Receptor Assembly.bioRxiv : the preprint server for biology · 2024
    Article
  8. Article
  9. The CH1 domain influences the expression and antigen sensing of the HIV-specific CH31 IgM-BCR and IgG-BCR.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 3 countries.

Md Alamgir HossainHuman Vaccine Institute, Duke University, Durham, NC, USA.
Kara AnastiHuman Vaccine Institute, Duke University, Durham, NC, USA.
Brian WattsHuman Vaccine Institute, Duke University, Durham, NC, USA.
Kenneth CroninHuman Vaccine Institute, Duke University, Durham, NC, USA.
Ronald DerkingHuman Vaccine Institute, Duke University, Durham, NC, USA.
Bettina GroschelDepartment of Immunology & Microbiology and Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.
Advaiti Pai KaneHuman Vaccine Institute, Duke University, Durham, NC, USA.
R J EdwardsHuman Vaccine Institute, Duke University, Durham, NC, USA.
David EasterhoffHuman Vaccine Institute, Duke University, Durham, NC, USA.
Jinsong ZhangApplied Biomedical Science Institute, San Diego, CA, USA.
Wes RountreeHuman Vaccine Institute, Duke University, Durham, NC, USA.
Yaneth OrtizDepartment of Molecular Immunology, Faculty of Biology, University of Freiburg, Freiburg, Germany.
Kevin SaundersHuman Vaccine Institute, Duke University, Durham, NC, USA.
William R SchiefDepartment of Immunology & Microbiology and Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.
Rogier W SandersDepartment of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, Amsterdam, the Netherlands.
Laurent VerkoczyApplied Biomedical Science Institute, San Diego, CA, USA.
Michael RethSignaling Research Centers BIOSS and CIBSS, Freiburg, Germany; Department of Molecular Immunology, Faculty of Biology, University of Freiburg, Freiburg, Germany.
S Munir AlamHuman Vaccine Institute, Duke University, Durham, NC, USA; Department of Medicine & Pathology, Duke University, Durham, NC, USA. Electronic address: munir.alam@duke.edu.
Duke University · USApplied Biotechnology Institute · USScripps Research Institute · USUniversity of Freiburg · DEAmsterdam University Medical Centers · NL

Funding

Antigen recognition and activation of HIV-specific B cell antigen receptorsR01AI145656 · NIAID · DUKE UNIVERSITY · PI S. Munir ALAM, Laurent Karl Verkoczy · 2019 to 2026
$7.7M
NIAID NIH HHS R01 AI145656
6 · The paper itself

Abstract

HIV-1 envelope (Env) proteins designed to induce neutralizing antibody responses allow study of the role of affinities (equilibrium dissociation constant [K

Indexed as

HIV-1Antibodies, NeutralizingAntigens, Viralenv Gene Products, Human Immunodeficiency VirusHIV AntibodiesImmunoglobulin MReceptors, Antigen, B-CellAntibodies, NeutralizingAntigens, Viralenv Gene Products, Human Immunodeficiency VirusHIV AntibodiesImmunoglobulin MReceptors, Antigen, B-Cellaffinityantigen internalizationassociation rateB cellBCRcalcium mobilizationCP: ImmunologyenvelopeHIV-1IgMphospho-signaling

Identifiers

PMID35767950
PMCPMC9837990
OpenAlexW4283713019

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.